Why pulsatility still matters: A review of current knowledge

Croatian Medical Journal

Volumn 55, Issue 6, 2014, Pages 609-620

  Barić, Davor ^a  

^a University of Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN HEMORRHAGE; COCHRANE LIBRARY; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; EMBASE; HISTOLOGY; HUMAN; LIFE SUPPORT EQUIPMENT; MEDLINE; OPERATIVE BLOOD LOSS; POSTOPERATIVE HEMORRHAGE; PULSATILE FLOW; PULSATILE FLOW VENTRICULAR ASSIST DEVICE; THROMBOSIS; HEART ASSIST DEVICE; HEART FAILURE; PATHOPHYSIOLOGY; QUALITY OF LIFE;

HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; PULSATILE FLOW; QUALITY OF LIFE;

EID: 84921634364     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2014.55.609     Document Type: Article

References (97)

1. Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR, et al. The REMATCH trial: rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure. Ann Thorac Surg. 1999;67:723-30. Medline:10215217 doi:10.1016/S0003-4975(99)00042-9.
2. Dembitsky WP, Tector AJ, Park S, Moskowitz AJ, Gelijns AC, Ronan NS, et al. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial. Ann Thorac Surg. 2004;78:2123-9, discussion 2129-30. Medline:15561049 doi:10.1016/j.athoracsur.2004.02.030.
3. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-43. Medline:11794191 doi:10.1056/NEJMoa012175.
4. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006;355:1873-84. Medline:17079761 doi:10.1056/NEJMoa053063.
5. Frazier OH, Myers TJ. Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg. 1999;68:734-41. Medline:10475480 doi:10.1016/S0003-4975(99)00801-2.
6. Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, DiTullio M, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. 1998;98:2383-9. Medline:9832482 doi:10.1161/01.CIR.98.22.2383.
7. Simon MA, Kormos RL, Murali S, Nair P, Heffernan M, Gorcsan J, et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation. 2005;112(9 Suppl):I32-6. Medline:16159839 doi:10.1161/CIRCULATIONAHA.104.524124.
8. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg. 2003;237:631-6, discussion 636-7. Medline:12724629 doi:10.1097/01.SLA.0000064359.90219.44.
9. Yager JE, Felker GM. Left ventricular assist devices as destination therapy for end-stage heart failure. Am Heart J. 2004;148:252-3. Medline:15308994 doi:10.1016/j.ahj.2004.06.013.
10. Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, et al. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2014;63:1751-7. Medline:24613333 doi:10.1016/j.jacc.2014.01.053.
11. Haft J, Armstrong W, Dyke DB, Aaronson KD, Koelling TM, Farrar DJ, et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation. 2007;116(11 Suppl):I8-15. Medline:17846330 10.1161/CIRCULATIONAHA.106.677898.
12. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-51. Medline:19920051 doi:10.1056/NEJMoa0909938.
13. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010;55:1826-34. Medline:20413033 doi:10.1016/j.jacc.2009.12.052.
14. Hickey PR, Buckley MJ, Philbin DM. Pulsatile and nonpulsatile cardiopulmonary bypass: review of a counterproductive controversy. Ann Thorac Surg. 1983;36:720-7. Medline:6360057 doi:10.1016/S0003-4975(10)60286-X.
15. Wilson E, Mai Q, Sudhir K, Weiss RH, Ives HE. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol. 1993;123:741-7. Medline:8227136 doi:10.1083/jcb.123.3.741.
16. Burton AC. Relation of structure to function of the tissues of the wall of blood vessels. Physiol Rev. 1954;34:619-42. Medline:13215088.
17. Takeda J. Experimental study of peripheral circulation during extracorporeal circulation with a special reference to a comparison of pulsatile flow with non-pulsatile flow. Arch Jap Chir. 1960;29:1407-12.
18. Prior FG, Gourlay T, Taylor KM. Pulse reverse osmosis: a new theory in the maintenance of fluid balance. Perfusion. 1995;10:159-70. Medline:7579766 doi:10.1177/026765919501000307.
19. Baba A, Dobsak P, Saito I, Isoyama T, Takiura K, Abe Y, et al. Microcirculation of the bulbar conjunctiva in the goat implanted with a total artificial heart: effects of pulsatile and nonpulsatile flow. ASAIO J. 2004;50:321-7. Medline:15307541.
20. Undar A, Fraser CD Jr. The alphabet of research on pulsatile and nonpulsatile (continuous flow) perfusion during chronic support. Artif Organs. 2002;26:812-3. Medline:12197939 doi:10.1046/j.1525-1594.2002.00919.x.
21. Shepard RB, Simpson DC, Sharp JF. Energy equivalent pressure. Arch Surg. 1966;93:730-40. Medline:5921294 doi:10.1001/archsurg.1966.01330050034005.
22. Undar A, Frazier OH, Fraser CD Jr. Defining pulsatile perfusion: quantification in terms of energy equivalent pressure. Artif Organs. 1999;23:712-6. Medline:10463494 doi:10.1046/j.1525-1594.1999.06409.x.
23. Ündar A. Energy equivalent pressure formula is for precise quantification of different perfusion modes. Ann Thorac Surg. 2003;76:1777-8. Medline:14602350 doi:10.1016/S0003-4975(03)00668-4.
24. Undar A. Pulsatile versus nonpulsatile cardiopulmonary bypass procedures in neonates and infants: from bench to clinical practice. ASAIO J. 2005;51:vi-x. Medline:16322700 doi:10.1097/01.mat.0000178215.34588.98.
25. Travis AR, Giridharan GA, Pantalos GM, Dowling RD, Prabhu SD, Slaughter MS, et al. Vascular pulsatility in patients with a pulsatileor continuous-flow ventricular assist device. J Thorac Cardiovasc Surg. 2007;133:517-24. Medline:17258591 doi:10.1016/j.jtcvs.2006.09.057.
26. Soucy KG, Koenig SC, Giridharan GA, Sobieski MA, Slaughter MS. Defining pulsatility during continuous-flow ventricular assist device support. J Heart Lung Transplant. 2013;32:581-7. Medline:23540401 doi:10.1016/j.healun.2013.02.010.
27. Potapov EV, Loebe M, Nasseri BA, Sinawski H, Koster A, Kuppe H, et al. Pulsatile flow in patients with a novel nonpulsatile implantable ventricular assist device. Circulation. 2000;102(19 Suppl 3):III183-7. Medline:11082384.
28. Bearnson GB, Olsen DB, Khanwilkar PS, Long JW, Allaire PE, Maslen EH. Pulsatile operation of a centrifugal ventricular assist device with magnetic bearings. ASAIO J. 1996;42:M620-4. Medline:8944955 doi:10.1097/00002480-199609000-00062.
29. Moazami N, Fukamachi K, Kobayashi M, Smedira NG, Hoercher KJ, Massiello A, et al. Axial and centrifugal continuous-flow rotary pumps: a translation from pump mechanics to clinical practice. J Heart Lung Transplant. 2013;32:1-11. Medline:23260699 doi:10.1016/j.healun.2012.10.001.
30. Bourque K, Dague C, Farrar D, Harms K, Tamez D, Cohn W, et al. In vivo assessment of a rotary left ventricular assist deviceinduced artificial pulse in the proximal and distal aorta. Artif Organs. 2006;30:638-42. Medline:16911321 doi:10.1111/j.1525-1594.2006.00276.x.
31. Ising M, Warren S, Sobieski M, Slaughter M, Koenig S, Giridharan G. Flow modulation algorithms for continuous flow left ventricular assist devices to increase vascular pulsatility: a computer simulation study. Cardiovascular engineering and technology. 2011;2:90-100. doi:10.1007/s13239-011-0042-x.
32. Koenig SC, Pantalos GM, Gillars KJ, Ewert DL, Litwak KN, Etoch SW. Hemodynamic and pressure-volume responses to continuous and pulsatile ventricular assist in an adult mock circulation. ASAIO J. 2004;50:15-24. Medline:14763487 doi:10.1097/01.MAT.0000104816.50277.EB.
33. Bartoli CR, Giridharan GA, Litwak KN, Sobieski M, Prabhu SD, Slaughter MS, et al. Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricle. ASAIO J. 2010;56:410-6. Medline:20613490 doi:10.1097/MAT.0b013e3181e7bf3c.
34. Garcia S, Kandar F, Boyle A, Colvin-Adams M, Lliao K, Joyce L, et al. Effects of pulsatile-and continuous-flow left ventricular assist devices on left ventricular unloading. J Heart Lung Transplant. 2008;27:261-7. Medline:18342746 doi:10.1016/j.healun.2007.12.001.
35. Kato TS, Chokshi A, Singh P, Khawaja T, Cheema F, Akashi H, et al. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail. 2011;4:546-53. Medline:21765125 doi:10.1161/CIRCHEARTFAILURE.111.962142.
36. Klotz S, Deng MC, Stypmann J, Roetker J, Wilhelm MJ, Hammel D, et al. Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. Ann Thorac Surg. 2004;77:143-9, discussion 149-50. Medline:14726050 doi:10.1016/S0003-4975(03)01336-5.
37. John R, Liao K, Kamdar F, Eckman P, Boyle A, Colvin-Adams M. Effects on pre-and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2010;140:447-52. Medline:20435321 doi:10.1016/j.jtcvs.2010.03.006.
38. Ozturk P, Engin AY, Nalbantgil S, Oguz E, Ayik F, Engin C, et al. Comparison of continuous-flow and pulsatile-flow blood pumps on reducing pulmonary artery pressure in patients with fixed pulmonary hypertension. Artif Organs. 2013;37:763-7. Medline:24033601 doi:10.1111/aor.12164.
39. Davies PF, Barbee KA, Volin MV, Robotewskyj A, Chen J, Joseph L, et al. Spatial relationships in early signaling events of flow-mediated endothelial mechanotransduction. Annu Rev Physiol. 1997;59:527-49. Medline:9074776 doi:10.1146/annurev.physiol.59.1.527.
40. Barakat A, Lieu D. Differential responsiveness of vascular endothelial cells to different types of fluid mechanical shear stress. Cell Biochem Biophys. 2003;38:323-43. Medline:12794271 doi:10.1385/CBB:38:3:323.
41. Nakata M, Tatsumi E, Tsukiya T, Taenaka Y, Nishimura T, Nishinaka T, et al. Augmentative effect of pulsatility on the wall shear stress in tube flow. Artif Organs. 1999;23:727-31. Medline:10463497 doi:10.1046/j.1525-1594.1999.06411.x.
42. Nakano T, Tominaga R, Morita S, Masuda M, Nagano I, Imasaka K, et al. Impacts of pulsatile systemic circulation on endotheliumderived nitric oxide release in anesthetized dogs. Ann Thorac Surg. 2001;72:156-62. Medline:11465171 doi:10.1016/S0003-4975(01)02644-3.
43. Canty JM Jr, Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation. 1994;89:375-84. Medline:8281673 doi:10.1161/01.CIR.89.1.375.
44. Hornick P, Taylor K. Pulsatile and nonpulsatile perfusion: the continuing controversy. J Cardiothorac Vasc Anesth. 1997;11:310-5. Medline:9161899 doi:10.1016/S1053-0770(97)90100-2.
45. Videcoq M, Desmonts JM, Marty J, Hazebroucq J, Langlois J. Effects of droperidol on peripheral vasculature: use of cardiopulmonary bypass as a study model. Acta Anaesthesiol Scand. 1987;31:370-4. Medline:3630580 doi:10.1111/j.1399-6576.1987.tb02586.x.
46. Habazettl H, Kukucka M, Weng YG, Kuebler WM, Hetzer R, Kuppe H, et al. Arteriolar blood flow pulsatility in a patient before and after implantation of an axial flow pump. Ann Thorac Surg. 2006;81:1109-11. Medline:16488735 doi:10.1016/j.athoracsur.2004.12.030.
47. Nishimura T, Tatsumi E, Takaichi S, Taenaka Y, Wakisaka Y, Nakatani T, et al. Morphologic changes of the aortic wall due to reduced systemic pulse pressure in prolonged non pulsatile left heart bypass. ASAIO J. 1997;43:M691-5. Medline:9360135 doi:10.1097/00002480-199703000-00169.
48. Nishimura T, Tatsumi E, Nishinaka T, Taenaka Y, Nakata M, Takano H. Prolonged nonpulsatile left heart bypass diminishes vascular contractility. Int J Artif Organs. 1999;22:492-8. Medline:10493557.
49. Kihara S, Litwak KN, Nichols L, Litwak P, Kameneva MV, Wu Z, et al. Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist. Ann Thorac Surg. 2003;75:178-83, discussion 183. Medline:12537213 doi:10.1016/S0003-4975(02)04087-0.
50. Potapov EV, Dranishnikov N, Morawietz L, Stepanenko A, Rezai S, Blechschmidt C, et al. Arterial wall histology in chronic pulsatileflow and continuous-flow device circulatory support. J Heart Lung Transplant. 2012;31:1171-6. Medline:22995552 doi:10.1016/j.healun.2012.08.013.
51. Sezai A, Shiono M, Orime Y, Nakata K, Hata M, Iida M, et al. Major organ function under mechanical support: comparative studies of pulsatile and nonpulsatile circulation. Artif Organs. 1999;23:280-5. Medline:10198721 doi:10.1046/j.1525-1594.1999.06318.x.
52. Sezai A, Shiono M, Orime Y, Nakata K, Hata M, Nemoto M, et al. Comparison studies of major organ microcirculations under pulsatile-and nonpulsatile-assisted circulations. Artif Organs. 1996;20:139-42. Medline:8712958 doi:10.1111/j.1525-1594.1996.tb00716.x.
53. Orime Y, Shiono M, Nakata K, Hata M, Sezai A, Yamada H, et al. The role of pulsatility in end-organ microcirculation after cardiogenic shock. ASAIO J. 1996;42:M724-9. Medline:8944976 doi:10.1097/00002480-199609000-00083.
54. Saito S, Westaby S, Piggot D, Dudnikov S, Robson D, Catarino PA, et al. End-organ function during chronic nonpulsatile circulation. Ann Thorac Surg. 2002;74:1080-5. Medline:12400749 doi:10.1016/S0003-4975(02)03846-8.
55. Golding LR, Jacobs G, Murakami T, Takatani S, Valdés F, Harasaki H, et al. Chronic nonpulsatile blood flow in an alive, awake animal 34-day survival. Trans Am Soc Artif Intern Organs. 1980;26:251-5. Medline:7245493.
56. Letsou GV, Myers TJ, Gregoric ID, Delgado R, Shah N, Robertson K, et al. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann Thorac Surg. 2003;76:1167-70. Medline:14530006 doi:10.1016/S0003-4975(03)00724-0.
57. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH. End-organ function in patients on long-term circulatory support with continuous-or pulsatile-flow assist devices. J Heart Lung Transplant. 2007;26:815-8. Medline:17692785 doi:10.1016/j.healun.2007.05.012.
58. Kamdar F, Boyle A, Liao K, Colvin-adams M, Joyce L, John R. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant. 2009;28:352-9. Medline:19332262 doi:10.1016/j.healun.2009.01.005.
59. Deo SV, Sharma V, Cho YH, Shah IK, Park SJ. De novo aortic insufficiency during long-term support on a left ventricular assist device: a systematic review and meta-analysis. ASAIO J. 2014;60:183-8. Medline:24399060 doi:10.1097/MAT.0000000000000042.
60. Pak SW, Uriel N, Takayama H, Cappleman S, Song R, Colombo PC, et al. Prevalence of de novo aortic insufficiency during longterm support with left ventricular assist devices. J Heart Lung Transplant. 2010;29:1172-6. Medline:20619680 doi:10.1016/j.healun.2010.05.018.
61. Hatano M, Kinugawa K, Shiga T, Kato N, Endo M, Hisagi M, et al. Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device. Circ J. 2011;75:1147-55. Medline:21378448 doi:10.1253/circj. CJ-10-1106.
62. Humphrey JD. Continuum biomechanics of soft biological tissues. Proc R Soc Lond. 2003;459:3-46. doi:10.1098/rspa.2002.1060.
63. May-Newman K, Enriquez-Almaguer L, Posuwattanakul P, Dembitsky W. Biomechanics of the aortic valve in the continuous flow VAD-assisted heart. ASAIO J. 2010;56:301-8. doi:10.1097/MAT.0b013e3181e321da Medline:20559132.
64. Cowger J, Pagani FD, Haft JW, Romano MA, Aaronson KD, Kolias TJ. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail. 2010;3:668-74. Medline:20739615 doi:10.1161/CIRCHEARTFAILURE.109.917765.
65. Mudd JO, Cuda JD, Halushka M, Soderlund KA, Conte JV, Russell SD. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transplant. 2008;27:1269-74. Medline:19059105 doi:10.1016/j.healun.2008.05.029.
66. Rose AG, Park SJ, Bank AJ, Miller LW. Partial aortic valve fusion induced by left ventricular assist device. Ann Thorac Surg. 2000;70:1270-4. Medline:11081884 doi:10.1016/S0003-4975(00)01929-9.
67. Martina JR, Schipper ME, de Jonge N, Ramjankhan F, de Weger RA, Lahpor JR, et al. Analysis of aortic valve commissural fusion after support with continuous-flow left ventricular assist device. Interact Cardiovasc Thorac Surg. 2013;17:616-24. Medline:23798641 doi:10.1093/icvts/ivt263.
68. Letsou GV, Connelly JH, Delgado RM III, Myers TJ, Gregoric ID, Smart FW, et al. Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? J Heart Lung Transplant. 2006;25:395-9. Medline:16563967 doi:10.1016/j.healun.2005.11.451.
69. Genovese EA, Dew MA, Teuteberg JJ, Kay J, Siegenthaler MP, Bhama JK, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg. 2009;88:1162-70. Medline:19766801 doi:10.1016/j.athoracsur.2009.06.028.
70. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-96. Medline:17761592 doi:10.1056/NEJMoa067758.
71. Suarez J, Patel CB, Felker GM, Becker R, Hernandez AF, Rogers JG. Mechanisms of bleeding and approach to patients with axialflow left ventricular assist devices. Circ Heart Fail. 2011;4:779-84. Medline:22086831 doi:10.1161/CIRCHEARTFAILURE.111.962613.
72. John R, Naka Y, Smedira NG, Starling R, Jorde U, Eckman P, et al. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. Ann Thorac Surg. 2011;92:1406-13. Medline:21958789 doi:10.1016/j.athoracsur.2011.05.080.
73. Schaffer JM, Arnaoutakis GJ, Allen JG, Weiss ES, Patel ND, Russell SD, et al. Bleeding complications and blood product utilization with left ventricular assist device implantation. Ann Thorac Surg. 2011;91:740-7, discussion 747-9. Medline:21352991 doi:10.1016/j.athoracsur.2010.11.007.
74. Lahpor J, Khaghani A, Hetzer R, Pavie A, Friedrich I, Sander K, et al. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg. 2010;37:357-61. Medline:19616963 doi:10.1016/j.ejcts.2009.05.043.
75. Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, et al. Results of the post-U.S. Food and Drug Administrationapproval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2011;57:1890-8. Medline:21545946 doi:10.1016/j.jacc.2010.10.062.
76. Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant. 2005;24:105-9. Medline:15653390 doi:10.1016/j.healun.2003.10.018.
77. Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009;137:208-15. Medline:19154927 doi:10.1016/j.jtcvs.2008.07.032.
78. Stern DR, Kazam J, Edwards P, Maybaum S, Bello RA, D'Alessandro DA, et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg. 2010;25:352-6. Medline:20331479 doi:10.1111/j.1540-8191.2010.01025.x.
79. Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2011;30:849-53. Medline:21530318 doi:10.1016/j.healun.2011.03.008.
80. Muthiah K, Robson D, Macdonald PS, Keogh AM, Kotlyar E, Granger E, et al. Increased incidence of angiodysplasia of the gastrointestinal tract and bleeding in patients with continuous flow left ventricular assist devices (LVADs). Int J Artif Organs. 2013;36:449-54. Medline:23897227 doi:10.5301/ijao.5000224.
81. Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet. 1992;340:35-7. Medline:1351610 doi:10.1016/0140-6736(92)92434-H.
82. Heyde E. Gastrointestinal bleeding in aortic stenosis. N Engl J Med. 1958;259:196. doi:10.1056/NEJM195807242590416.
83. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349:343-9. Medline:12878741 doi:10.1056/NEJMoa022831.
84. Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg. 2008;33:679-84. Medline:18282712 doi:10.1016/j.ejcts.2007.12.047.
85. Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail. 2010;3:675-81. Medline:20739614 doi:10.1161/CIRCHEARTFAILURE.109.877597.
86. Steinlechner B, Dworschak M, Birkenberg B, Duris M, Zeidler P, Fischer H, et al. Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg. 2009;87:131-7. Medline:19101285 doi:10.1016/j.athoracsur.2008.10.027.
87. Crow S, Milano C, Joyce L, Chen D, Arepally G, Bowles D, et al. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. ASAIO J. 2010;56:441-5. Medline:20613494 doi:10.1097/MAT.0b013e3181e5de0a.
88. Malehsa D, Meyer AL, Bara C, Struber M. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Eur J Cardiothorac Surg. 2009;35:1091-3. Medline:19303790 doi:10.1016/j.ejcts.2009.01.042.
89. Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TA, Sutton RE, et al. Endothelial von Willebrand factor regulates angiogenesis. Blood. 2011;117:1071-80. Medline:21048155 doi:10.1182/blood-2010-01-264507.
90. Lazar RM, Shapiro PA, Jaski BE, Parides MK, Bourge RC, Watson JT, et al. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation. 2004;109:2423-7. Medline:15123534 doi:10.1161/01.CIR.0000129414.95137.CD.
91. John R, Kamdar F, Liao K, Colvin-Adams M, Miller L, Joyce L, et al. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg. 2008;136:1318-23. Medline:19026822 doi:10.1016/j.jtcvs.2007.12.077.
92. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, et al. Extended mechanical circulatory support with a continuousflow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312-21. Medline:19608028 doi:10.1016/j.jacc.2009.03.055.
93. Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28:881-7. Medline:19716039 doi:10.1016/j.healun.2009.05.018.
94. Freed BH, Jeevanandam V, Jolly N. Aortic root and valve thrombosis after implantation of a left ventricular assist device. J Invasive Cardiol. 2011;23:E63-5. Medline:21474853.
95. Weymann A, Rudiger Simon A, Popov AF. Aortic root thrombosis after HeartWare implantation. Asian Cardiovasc Thorac Ann. 2014 0218492314544159. [Epub ahead of print]. Medline:25015654.
96. Raina A, Agarwal R, Benza RL. Spontaneous microbubbles in the aortic root and thrombosis of a continuous-flow left ventricular assist device. J Heart Lung Transplant. 2014;33:550-1. Medline:24630862 doi:10.1016/j.healun.2014.02.001.
97. Shah S, Mehra MR, Couper GS, Desai AS. Continuous flow left ventricular assist device related aortic root thrombosis complicated by left main coronary artery occlusion. J Heart Lung Transplant. 2014;33:119-20. Medline:24418738 doi:10.1016/j.healun.2013.12.003.